SEQUENTIAL

About

Sequential advances personal care and health research by studying the real-world impact of products through human clinical testing, biomarker discovery, and next-generation formulations across skin, scalp, oral, and vaginal care. Our end-to-end, in-house platform, from study design and participant recruitment (tailored to any required criteria) to laboratory analysis and data interpretation, turns complex biological data into clear, actionable insights. By combining microbial and molecular analyses, we enable the development of credible, effective, and trustworthy products and claims. With a database of over 50,000 samples, 4,000+ ingredients, and 10,000+ participants worldwide, Sequential leverages years of scientific expertise to set the standard for data-driven innovation and product validation in the personal care and pharmaceutical industries.

Product

Value proposition

End-to-end clinical research platform for skin, scalp, intimate & oral products, delivering human clinical testing, biomarker discovery, and next-generation formulations powered by a multi-omics platform to translate microbial/molecular data into actionable outcomes for product Credibility, efficacy, and consumer trust.

Target customers

cosmetics brands, dermocosmetics, dermatology-focused product developers

Founders

• Dr. Oliver Worsley — Co-founder and CEO
• Dr. Albert Dashi — Co-founder and CSO
• Petronille Houdart

Key features

Technologies

Notable customers

Partnerships

Traction metrics

News

• Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients · 2026-03-17T10:00:00.000Z
• Sequential raises $3.5M to scale AI-led ingredient discovery across skin and ingestible health · 2026-03-23T22:34:15.000Z
• Sequential raises $3.5m for microbiome clinical validation goal · 2026-03-23T09:34:12.000Z
• Sequential banks $3.5m for smarter skin health · 2026-03-20T17:46:26.000Z
• Sequential Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing & Skin Health Ingredients - SOSV · 2026-03-17T18:22:17.000Z
• Sequential secures £2.6m seed startup funding | Startupmag | Startupmag · 2026-03-17T09:27:00.000Z

Browse similar startups

Related startups

• Serenity Mobile Diagnostics LLC — Bronx, NY
• Snacc — New York, NY
• SUFFOLK PEDIATRIC ASSOCIATES, P.C — West Islip, NY
• The DR K Podcast — New York, NY
• ThriveOrtho — New York, NY
• Upsilon Health — New York, NY
• SereniCare AI — Denver, CO
• Serenity Behavioral Health & Wellness LLC — Savage, MN
• Shankel's Pharmacy — Du Bois, PA
• Shaws Pharmacy — Shrewsbury, MA
• Shelton Diagnostics INC — Nashville, TN
• SHENANDOAH ORAL AND FACIAL SURGERY, PLC — Rockingham, VA